Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19

被引：21

作者：

Fouladseresht, Hamed ^{[1
]}

Doroudchi, Mehrnoosh ^{[2
]}

Rokhtabnak, Najmeh ^{[3
]}

Abdolrahimzadehfard, Hossein ^{[1
]}

Roudgari, Amir ^{[1
]}

Sabetian, Golnar ^{[1
]}

Paydar, Shahram ^{[1
]}

机构：

[1] Shiraz Univ Med Sci, Shahid Rajaee Emtiaz Trauma Hosp, Trauma Res Ctr, Shiraz, Iran

[2] Shiraz Univ Med Sci, Sch Med, Dept Immunol, Shiraz, Iran

[3] Shahid Bahonar Univ Kerman, Dept Biol, Fac Sci, Kerman, Iran

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2021年 / 58卷

关键词：

COVID-19; Biomarker; Immunopathology; Cytokine storm; Lung; Complications; RESPIRATORY-DISTRESS-SYNDROME; SURFACTANT PROTEIN-D; SARS CORONAVIRUS; SPIKE PROTEIN; RESPONSES; INTERFERON; INHIBITION; NECROSIS; IGG; COV;

D O I：

10.1016/j.cytogfr.2020.10.002

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARSCoV-2), appears with a wide spectrum of mild-to-critical clinical complications. Many clinical and experimental findings suggest the role of inflammatory mechanisms in the immunopathology of COVID-19. Hence, cellular and molecular mediators of the immune system can be potential targets for predicting, monitoring, and treating the progressive complications of COVID-19. In this review, we assess the latest cellular and molecular data on the immunopathology of COVID-19 according to the pathological evidence (e.g., mucus and surfactants), dysregulations of proand anti-inflammatory mediators (e.g., cytokines and chemokines), and impairments of innate and acquired immune system functions (e.g., mononuclear cells, neutrophils and antibodies). Furthermore, we determine the significance of immune biomarkers for predicting, monitoring, and treating the progressive complications of COVID-19. We also discuss the clinical importance of recent immune biomarkers in COVID-19, and at the end of each section, recent clinical trials in immune biomarkers for COVID-19 are mentioned.

引用

页码：32 / 48

页数：17

共 159 条

[1] Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits [J].

Ahlstrom, J. Zebialowicz ;

Massaro, F. ;

Mikolka, P. ;

Feinstein, R. ;

Perchiazzi, G. ;

Basabe-Burgos, O. ;

Curstedt, T. ;

Larsson, A. ;

Johansson, J. ;

Rising, A. .

RESPIRATORY RESEARCH, 2019, 20 (01)

[2] Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study [J].

Alsofayan, Yousef M. ;

Althunayyan, Saqer M. ;

Khan, Anas A. ;

Hakawi, Ahmed M. ;

Assiri, Abdullah M. .

JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (07) :920-925

[3]

[Anonymous], 2020, Nat. Commun

[4] When aging reaches CD4+T-cells: phenotypic and functional changes [J].

Antonio Moro-Garcia, Marco ;

Alonso-Arias, Rebeca ;

Lopez-Larrea, Carlos .

FRONTIERS IN IMMUNOLOGY, 2013, 4

[5] Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study [J].

Arabi, Yaseen M. ;

Shalhoub, Sarah ;

Mandourah, Yasser ;

Al-Hameed, Fahad ;

Al-Omari, Awad ;

Al Qasim, Eman ;

Jose, Jesna ;

Alraddadi, Basem ;

Almotairi, Abdullah ;

Al Khatib, Kasim ;

Abdulmomen, Ahmed ;

Qushmaq, Ismael ;

Sindi, Anees A. ;

Mady, Ahmed ;

Solaiman, Othman ;

Al-Raddadi, Rajaa ;

Maghrabi, Khalid ;

Ragab, Ahmed ;

Al Mekhlafi, Ghaleb A. ;

Balkhy, Hanan H. ;

Al Harthy, Abdulrahman ;

Kharaba, Ayman ;

Gramish, Jawaher A. ;

Al-Aithan, Abdulsalam M. ;

Al-Dawood, Abdulaziz ;

Merson, Laura ;

Hayden, Frederick G. ;

Fowler, Robert .

CLINICAL INFECTIOUS DISEASES, 2020, 70 (09) :1837-1844

[6] Presumed Asymptomatic Carrier Transmission of COVID-19 [J].

Bai, Yan ;

Yao, Lingsheng ;

Wei, Tao ;

Tian, Fei ;

Jin, Dong-Yan ;

Chen, Lijuan ;

Wang, Meiyun .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14) :1406-1407

[7]

Braun Julian., 2020, medRxiv, DOI [10.1101/2020.04.17.20061440, DOI 10.1101/2020.04.17.20061440]

[8] The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities [J].

Buja, Louis Maximilian ;

Wolf, Dwayne A. ;

Zhao, Bihong ;

Akkanti, Bindu ;

McDonald, Michelle ;

Lelenwa, Laura ;

Reilly, Noah ;

Ottaviani, Giulia ;

Elghetany, M. Tarek ;

Trujillo, Daniel Ocazionez ;

Aisenberg, Gabriel M. ;

Madjid, Mohammad ;

Kar, Biswajit .

CARDIOVASCULAR PATHOLOGY, 2020, 48

[9] Mechanical Ventilation-associated Lung Fibrosis in Acute Respiratory Distress Syndrome A Significant Contributor to Poor Outcome [J].

Cabrera-Benitez, Nuria E. ;

Laffey, John G. ;

Parotto, Matteo ;

Spieth, Peter M. ;

Villar, Jesus ;

Zhang, Haibo ;

Slutsky, Arthur S. .

ANESTHESIOLOGY, 2014, 121 (01) :189-198

[10] Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome [J].

Cameron, Mark J. ;

Ran, Longsi ;

Xu, Luoling ;

Danesh, Ali ;

Bermejo-Martin, Jesus F. ;

Cameron, Cheryl M. ;

Muller, Matthew P. ;

Gold, Wayne L. ;

Richardson, Susan E. ;

Poutanen, Susan M. ;

Willey, Barbara M. ;

DeVries, Mark E. ;

Fang, Yuan ;

Seneviratne, Charit ;

Bosinger, Steven E. ;

Persad, Desmond ;

Wilkinson, Peter ;

Greller, Larry D. ;

Somogyi, Roland ;

Humar, Atul ;

Keshavjee, Shaf ;

Louie, Marie ;

Loeb, Mark B. ;

Brunton, James ;

McGeer, Allison J. ;

Kelvin, David J. .

JOURNAL OF VIROLOGY, 2007, 81 (16) :8692-8706

← 1 2 3 4 5 6 7 8 9 10 →